Published online 16 February 2005
Methods Online |
Use of mRNA- and protein-destabilizing elements to develop a highly responsive reporter system
1 GeneStream Pty Ltd 96 Chipping Road, City Beach, WA 6015, Australia 2 Department of Clinical Immunology and Biochemical Genetics, Royal Perth Hospital Wellington Street, Perth WA 6000, Australia 3 School of Surgery and Pathology, The University of Western Australia Crawley WA 6009, Australia
*To whom correspondence should be addressed. Tel/Fax: +61 8 92051149; Email: johndaly{at}genestream.com.au
Received October 26, 2004. Revised December 24, 2004. Accepted January 23, 2005.
Reporter assays are widely used in applications that require measurement of changes in gene expression over time (e.g. drug screening). With standard reporter vectors, the measurable effect of a treatment or compound (altered reporter activity) is substantially diluted and delayed, compared with its true effect (altered transcriptional activity). This problem is caused by the relatively long half-lives of both the reporter protein and its mRNA. As a result, the activities of compounds, ligands or treatments that have a relatively minor effect, or a substantial but transient effect, often remain undetected. To circumvent this problem, we introduced modular protein- and mRNA-destabilizing elements into a range of commonly used reporters. Our data show that both elements are required for maximal responses to both increases and decreases in transcriptional activity. The double-destabilized reporter vectors showed markedly improved performance in drug screening, kinetic assays and doseresponse titrations.
The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors